Beijing to tighten biotech exports as big-ticket Chinese pharma dealmaking soars
Proposed export regime for cell and gene therapy, siRNA platform technologies allows IP licensing while keeping ownership in China
Proposed export regime for cell and gene therapy, siRNA platform technologies allows IP licensing while keeping ownership in China